We previously reported that a multifunctional envelope-type nano device (MEND) modified with a 20 GALA peptide (GALA/MEND) exerted dual functions; effective targeting the pulmonary 21 endothelium and endosomal escape. The GALA/MEND containing encapsulated siRNA was originally 22 prepared by the film coated hydration method (GALA/MEND Hyd ). However, an ethanol dilution method 23 was found to be appropriate for scaling up the preparation of this liposomal nanoparticle. In this 24 study, we report on the preparation of a GALA/MEND based on the principal of the ethanol dilution 25 
Introduction 38
Specific gene silencing with RNA interference (RNAi) is a highly promising strategy for currently 39 siRNA/polycation core solution in water, followed by sonication. However, mass production is 74 hampered by the flask size used for preparing the lipid film and heterogeneous irradiation of the 75 sonication energy. In order to manufacture the GALA/MEND in quantities needed for preclinical 76
and clinical development, a preparation based on the principal of ethanol dilution (Jeffs et al., 2005 ) 77 is more simple, robust and potent, in terms of scaling up. 78
The first effort to achieve this was focused on preparing the GALA-MEND by the ethanol dilution 79 method. As described below, we found that the gene knockdown efficacy of the GALA-MEND 80 prepared by the ethanol dilution method (GALA/MEND EtOH ) was higher than that for the 81 GALA-MEND prepared by the lipid hydration method (GALA/MEND Hyd ). Thus, we gained insights 82 into the mechanism for the preferred gene knockdown efficacy of the GALA/MEND EtOH by 83 comparing the pharmacokinetics and intracellular trafficking between it and the original 84 GALA/MEND Hyd . 85
86

Materials and methods 87
Preparation of MENDs by the lipid hydration method 88
The sequences of the siRNA and primers used in quantitative RT-PCR were reported in a previous 89 article ( Kusumoto et al., 2013) . siRNA and PEI were first dissolved in a 10 mM HEPES buffer (pH 7.4) 90 containing 5% glucose (HBG). 200 μL of PEI (0.125 mg/mL) was added to 300 μL of siRNA (0.33 91 mg/mL) to form a complex at a nitrogen/phosphate ratio of 1.8. A lipid film was formed by the 92 evaporation of an ethanol solution containing 2.64 μmol of total lipids of 93 DOTMA/Chol/EPC/STR-mPEG (30:40:30:5). To prepare the GALA/MEND Hyd , 2 mol% of Chol-GALA 94 was added to the lipid composition. The siRNA/PEI complex was applied to the lipid film, followed by 95 incubation for 15 min at room temperature to hydrate the lipids. To encapsulate the siRNA/PEI complex 96 in the lipid, the lipid film was sonicated for approximately 1 min in a bath-type sonicator. 97
Preparation of MENDs with ethanol dilution method 98
An 1.2 mL of ethanol solution containing 4.4 mM of total lipids of DOTMA/Chol/EPC/STR-mPEG 99 (30:40:30:5) was rapidly diluted with 2.8 mL of the siRNA/PEI core particle solution (0.2 mg of siRNA, 100 30 vol% ethanol). To prepare the GALA/MEND EtOH 2 mol% Chol-GALA was added to the lipid solution. 101
The solution was further diluted by adding 1.8 mL of HBG to give 15 vol% ethanol. The diluted solution 102 was concentrated by ultrafiltration using an Amicon Ultra 4 (Millipore Corp. Billerica, MA) by 103 centrifugation at 1,000g for 30 min at room temperature. The particle solution remaining on the upper 104 column was diluted with 4 mL of HBS, and again concentrated by centrifugation at 1,000g for 30 min at 105 room temperature. The diameter and zeta potential of the MENDs were determined using an 106 electrophoretic light-scattering spectrophotometer (Zetasizer; Malvern Instruments Ltd., Malvern, WR, 107 UK). Materials and any other methods can be found in the supplementary section. 108
Result and Discussion 110
In the present report, we encapsulated the siRNA/polyethyleneimine (PEI) complex within a lipid 111 The gene knockdown effects of the MENDs were evaluated using CD31 as an endothelial 126 cell-specific key gene. (Fig. 2) (Fig.2D) . The entrap 148 efficacy were about 70% regardless of preparation methods. Therefore, the improved gene knockdown 149 function of GALA/MEND EtOH cannot be explained from the pharmacokinetic and siRNA efficacy 150 points of view. 151
The efficacy of siRNA is also rate-limited by intracellular processing, including endosomal escape, 152 as well as the cellular uptake process (Khalil et al., 2006) . Thus, we evaluated the endosomal escape 153 process in HeLa cell between GALA/MEND Hyd and GALA/MEND EtOH by confocal laser scanning 154 microscopy at 6 h after the transfection. As shown in Figure 3 , the most significant finding is that 155 the GALA/MEND EtOH was dominantly observed free from the co-localization of 156 endosome/lysosome fraction. In contrast, the intracellular signals of GALA/MEND Hyd are 157 significantly poor in comparison with GALA/MEND EtOH prepared with ethanol dilution method. 158
One of the possible explanation is that the GALA/MEND Hyd is subject to the rapid degradation. This 159 hypothesis is also supported by the quantitative analysis of endosomal escape efficiency: the 160 endosomal escape in GALA/MEND Hyd was significantly lower than GALA/MEND EtOH . 161
Collectively, the more prominent gene knockdown efficiency for the GALA/MEND EtOH prior to the 162 GALA/MEND Hyd can be attributed to extensive endosome escape. 163
In conclusion, the GALA/MEND could be prepared by the ethanol dilution method, which is 164 desirably in terms of scaling up the preparation of the material. Also, the larger size of the 165 GALA/MEND EtOH resulted in a higher gene knockdown efficacy in comparison with 166 GALA/MEND Hyd owing to its rapid endosomal escape properties. Collectively, the ethanol dilution 167 method can be considered to be a promising technology for the mass-production and for upgrading 168 the function of the GALA/MEND as a lung-targeting siRNA carrier. Table  293   Table  294 Physi 295 
